Regd. Office. T-210 J, Shahpur Jat, New Delhi - 110 049 (INDIA)Press Release • February 21st, 2022
Contract Type FiledFebruary 21st, 2022This press release is provided for informational purposes only and does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for any interest in or securities of Jagsonpal Pharmaceuticals Limited, nor shall it, or any part hereof, form the basis of, or be relied on in connection with, any contract therefore.